Literature DB >> 34792581

Characterization of Mycophenolate Mofetil Gastrointestinal Toxicity and Risk Factors for Severe Disease and Poor Prognosis.

Sumona Bhattacharya1,2, Gianna Stoleru3, Preet Patel3, Ameer Abutaleb2, Kristen Stashek4, Raymond K Cross2.   

Abstract

Entities:  

Keywords:  mycophenolate mofetil; mycophenolate mofetil colitis; mycophenolate mofetil gastrointestinal toxicity

Mesh：

Substances：

Year:  2022        PMID： 34792581      PMCID： PMC9274997          DOI： 10.1093/ibd/izab254

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   7.290


× No keyword cloud information.
  10 in total

1.  Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis.

Authors:  George Liapis; John Boletis; Chrysanthi Skalioti; George Bamias; Katerina Tsimaratou; Efstratios Patsouris; Ioanna Delladetsima
Journal:  Histopathology       Date:  2013-09-11       Impact factor: 5.087

2.  Microscopic features associated with mycophenolate mofetil in gastric and colonic biopsies.

Authors:  John D Coyne; Fiona Campbell
Journal:  Histopathology       Date:  2012-11       Impact factor: 5.087

3.  Clinicopathologic features and outcome of mycophenolate-induced colitis in renal transplant recipients.

Authors:  Luis Gustavo M de Andrade; Maria Aparecida M Rodrigues; Fernando G Romeiro; Paula D Garcia; Mariana M Contti; Maria Fernanda C de Carvalho
Journal:  Clin Transplant       Date:  2014-09-16       Impact factor: 2.863

4.  Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: relationship with corticosteroid dosage, renal function, sex, and patient age.

Authors:  J M Puig; P Fernández-Crespo; J Lloveras; M Mir; V Iñigo; J M Manresa; J Masramón
Journal:  Transplant Proc       Date:  1999-09       Impact factor: 1.066

5.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

6.  Crohn's-like changes in the colon due to mycophenolate?

Authors:  I J Dalle; B D Maes; K P Geboes; W Lemahieu; K Geboes
Journal:  Colorectal Dis       Date:  2005-01       Impact factor: 3.788

7.  Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.

Authors:  Mona M Riskalla; Emily C Somers; Richard A Fatica; W Joseph McCune
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

8.  Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil.

Authors:  Megan K Selbst; William A Ahrens; Marie E Robert; Amy Friedman; Deborah D Proctor; Dhanpat Jain
Journal:  Mod Pathol       Date:  2009-03-27       Impact factor: 7.842

9.  Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.

Authors:  John C Papadimitriou; Charles B Cangro; Alexander Lustberg; Amr Khaled; Joseph Nogueira; Ann Wiland; Emilio Ramos; David K Klassen; Cinthia B Drachenberg
Journal:  Int J Surg Pathol       Date:  2003-10       Impact factor: 1.271

10.  Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation.

Authors:  Fernando H Calmet; Andres J Yarur; Geetha Pukazhendhi; Jawad Ahmad; Kalyan R Bhamidimarri
Journal:  Ann Gastroenterol       Date:  2015 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.